The following slide deck was published by Endologix Inc in conjunction with this event.
Endologix ([[ELGX]] +6%) announced its preliminary unaudited revenue for Q4 and FY 2018 to be ~$34M and $155.8M respectively. Total cash, equivalents, and
Investing.com – U.S. stocks were higher after the close on Friday, as gains in the Technology, Basic Materials and Industrials sectors led shares higher. At the close in NYSE, the...
WellCare Health Plans, Inc. (NYSE:WCG) delivered fourth-quarter 2018 adjusted operating earnings of $1.63 per share, beating the Zacks Consensus Estimate by 5.2%. This upside is...
Humana Inc.’s (NYSE:HUM) fourth-quarter 2018 operating earnings per share of $2.65 beat the Zacks Consensus Estimate by 4.7%. The bottom line also improved 28.6% year over...
Centene Inc. (NYSE:CNC) reported fourth-quarter 2018 adjusted earnings per share of $1.38, beating the Zacks Consensus Estimate of $1.33 by 3.8%. Also, the bottom line improved...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Moving Averages||Buy||Buy||Sell||Strong Sell||Strong Sell|
|Technical Indicators||BUY||BUY||Strong Sell||Strong Sell||Strong Sell|
|Summary||Buy||Buy||Strong Sell||Strong Sell||Strong Sell|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Bullish doji Star||5H||Current|
|Engulfing Bearish||30||1||Feb 15, 2019 03:00PM|
|On Neck Bearish||5H||2||Feb 14, 2019 11:00AM|
|Stick Sandwich||15||3||Feb 15, 2019 03:00PM|
|X T L Biopharma||2.606||2.670||2.360||+0.356||+15.83%||2.89K||15/02|
|Bank of America||29.11||29.31||28.67||+0.72||+2.54%||65.87M||15/02|
Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company's products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.Read More
|U.S. Commodity Futures Trading Commission (United States)||Start Trading|
|U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States)||$0||Start Trading|
|U.S. Commodity Futures Trading Commission (United States)||$250||Start Trading|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.